Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 881-890 of 969 for hematology

Edit search filters
  1. Biospecimen Resource for Hepatocellular Carcinoma Research

    Jacksonville, FL

  2. Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study of Clinical Outcomes Associated with Lenvatinib Treatment in Patients with Anaplastic Thyroid Cancer

    Rochester, MN

  4. Cell, Serum, and Buccal Bank for Patients with Chronic Myeloid Disorders and Acute Leukemia

    Rochester, MN

  5. A Study of Healthy Donor Volunteers to Provide Blood components Via Leukapheresis for In vitro Dendritic Cell Investigations

    Scottsdale/Phoenix, AZ

  6. Molecular Characterization of Renal Cell Carcinomas and Melanomas

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  8. A Study to Evaluate and Compare Effectiveness Among New Measuring Methods to Find Minimal Residual Disease Following Stem Cell Transplant for Multiple Myeloma

    Rochester, MN

  9. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types

    Rochester, MN

  10. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now

    Rochester, MN

.

Mayo Clinic Footer